Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New company Voyager Therapeutics to develop gene therapies for CNS disorders

Feb. 13, 2014

Ventrus Biosciences reports results from second phase III trial of diltiazem cream

Feb. 13, 2014

Celon Pharma patents new PDE9 inhibitors for neurodegenerative disorders

Feb. 13, 2014

Researchers at Roche disclose novel modulators of neurogenesis

Feb. 13, 2014

Jazz Pharmaceuticals launches Versacloz oral suspension in U.S.

Feb. 12, 2014

Omeros reports additional phase I data for OMS-824

Feb. 12, 2014

Phase II study data do not support development of ADX-71149 for anxious depression

Feb. 10, 2014

FDA grants orphan drug designation to NeuroVax for pediatric MS

Feb. 10, 2014

Novartis researchers reveal histamine H3 receptor antagonists

Feb. 10, 2014

Pfizer to perform phase Ib trial of PF-06342674 in MS

Feb. 10, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...